When a “Blocked Ear” Isn’t Obstructive ETD

The Dual Nature of Eustachian Tube Dysfunction

Eustachian tube dysfunction encompasses two primary forms. Obstructive ETD, the more commonly recognized type, occurs when the valve regulating airflow into the middle ear fails to open adequately. This can manifest acutely during rapid barometric pressure changes, such as during air travel or scuba diving, a phenomenon known as baro-challenge. Conversely, patulous ETD is characterized by the Eustachian tube valve becoming abnormally stuck in an open position. While the patient experience might be described similarly as a “blocked ear,” the underlying pathophysiology and subsequent treatment strategies diverge significantly.

The 2026 COSM event featured a panel discussion moderated by Tina C. T. Huang, MD, MS, a neurotologist and associate professor at the University of Minnesota Medical School. The panel brought together specialists to offer practical insights into the management of ETD, emphasizing the imperative of accurate diagnosis. Among the distinguished speakers were Dennis S. Poe, MD, PhD, a professor at Boston Children’s Hospital and Harvard Medical School, specializing in otology/neurotology and skull base surgery, and a leading figure in Eustachian tube research. Dr. Poe, principal investigator for multicenter clinical trials of balloon Eustachian tuboplasty, highlighted the underrecognized prevalence of patulous ETD and the critical need to distinguish it from its obstructive counterpart.

Seilesh C. Babu, MD, an assistant professor at Michigan State University, presented data on obstructive ETD in adults, focusing on the indications and evidence supporting balloon dilation. Judith E. C. Lieu, MD, MSPH, a professor at Washington University Medicine, addressed pediatric ETD, raising questions about the current utility of balloon dilation in children due to limited data and unresolved candidate selection criteria.

Patulous ETD: A More Prevalent Condition Than Previously Believed

A significant takeaway from the COSM panel was the critical importance of differentiating obstructive from patulous ETD in adults. While obstructive ETD is a frequent occurrence for many, patulous ETD, according to Dr. Poe and his colleagues, is far more prevalent than typically acknowledged in medical literature and clinical practice.

"Textbooks say that patulous ETD is rare, but it is not," stated Dr. Poe. "It is very common, but people don’t readily recognize it."

The symptoms of patulous ETD can be profoundly disruptive. Unlike obstructive ETD, where the tube remains shut, patulous ETD involves a valve that fails to close properly. This leads to autophony, a condition where an individual can hear their own voice or breathing amplified within their head, described by Dr. Poe as akin to speaking into a rubber hose connected to one’s ear. While a temporary form, often dubbed “runner’s ear,” can occur during dehydration or exercise and resolve with cooling, the chronic form can be debilitating, especially for professionals reliant on their voices, such as singers, teachers, and performers. Patients often describe the sensation as "Darth Vader breathing in their ear."

The implications of misdiagnosing patulous ETD as obstructive ETD are severe, particularly concerning the application of balloon dilation. As Dr. Poe cautioned, treating patulous ETD with balloon dilation could exacerbate the condition. Distinguishing between the two hinges on a thorough patient history and objective findings, areas where awareness of patulous ETD remains a critical gap for many clinicians.

Table 1: Symptom Differentiation in Eustachian Tube Dysfunction (Note: This would typically be a visual element in the original article, here described textually)

The hallmark symptoms of patulous ETD, according to Dr. Poe, include autophony, unusual ear popping and clicking, and a sensation of blockage that is often described as "muffled" rather than a true hearing loss seen in obstructive ETD. While audiograms often reveal normal hearing, the muffled sensation arises from altered resonance in the middle ear due to the abnormal air volume. Physical examination may reveal eardrum movement synchronized with breathing, which can be enhanced by having the patient breathe through the ipsilateral nostril. Tympanometry, specifically in the reflux decay mode, can provide a more sensitive assessment, revealing the Eustachian tube valve’s failure to close.

A significant contributing factor to patulous ETD, Dr. Poe explained, is the evolution from chronic inflammation leading to obstructive ETD. Over time, this can cause damage to the mucous membrane and secretory glands, leading to atrophy. This tissue thinning can result in the Eustachian tube valve becoming permanently stuck open. "Patients keep saying, ‘I have a blocked ear,’ so the otolaryngologist is thinking they still have obstructive ETD, without questioning whether it may have turned patulous," Dr. Poe observed.

Another critical diagnostic clue is frequent sniffing. Patients with patulous ETD often learn that sniffing generates negative pressure, temporarily closing the Eustachian tube valve and providing relief. This behavior, formerly termed "habitual sniffing," is a significant red flag. Patients may report that sniffing "unblocks" their ear, a misnomer as it actually closes the valve. Dr. Poe emphasized the importance of asking patients about autophony, frequent sniffing, and unusual ear popping and clicking. He also noted a common association between chronic allergic rhinitis and patulous ETD, advising heightened suspicion in allergic patients.

Navigating Treatment for Eustachian Tube Dysfunction

The management of ETD, whether obstructive or patulous, is highly individualized and dependent on identifying the root cause. Careful history taking is paramount in this diagnostic process.

Table 2: Comorbidities and First-Line Treatment Approaches for ETD (Note: This would typically be a visual element in the original article, here described textually)

For obstructive ETD in adults, initial treatment typically involves medical management aimed at addressing underlying etiologies. This may include antihistamines, nasal steroid sprays, and reflux management strategies. In cases of persistent adenoid or tubal tonsil hypertrophy, surgical intervention such as endoscopic adenoidectomy or careful trimming of tubal tonsil tissue may be indicated.

Treatment for patulous ETD focuses on restoring normal function and hydration. Maintaining adequate hydration, often with two liters of water daily, is crucial. Medications that can dry out mucous membranes, such as certain antihistamines, nasal steroid sprays, and decongestants, should be minimized or discontinued if clinically appropriate. Managing chronic allergic rhinitis through environmental controls, allergy testing, and immunotherapy is often a key component.

Dr. Poe highlighted the role of diuretics, including spironolactone found in some birth control pills and acne treatments, in contributing to patulous ETD due to their dehydrating effects. Switching to alternative medications has proven effective for many patients. The increasing prevalence of weight loss interventions, including GLP-1 agents and bariatric surgery, has also led to a rise in patulous ETD associated with rapid weight loss. While weight gain might seem intuitive, Dr. Poe advised against it unless medically indicated, as it often occurs in areas not beneficial for ETD.

Topical nasal drops, applied in a specific supine position with head tilt, can be highly effective. These drops, starting with saline and progressing to hypertonic saline or even a diluted lemon juice solution, aim to irritate the mucosa, temporarily closing the Eustachian tube valve and potentially allowing for mucosal rehabilitation and restoration of valve competency. Consistent application, often for two to three months, can yield lasting benefits.

A less commonly recognized cause of patulous ETD is tension in the jaw muscles, or temporomandibular joint (TMJ) dysfunction. Dr. Poe recommended referral to dentists specializing in oral medicine for management of masticatory muscle tension, which can directly impact the medial pterygoid muscle, an accessory dilator of the Eustachian tube.

Balloon Dilation: A Targeted Approach for Obstructive ETD

Balloon dilation of the Eustachian tube has emerged as a significant treatment option for carefully selected adults with obstructive ETD. However, its efficacy and appropriate use remain a subject of ongoing research and clinical discussion.

Dr. Babu’s research, presented at COSM, identified specific criteria for optimal candidates for balloon dilation. These include the presence of clinical symptoms, objective findings as outlined in Table 1, and a documented failure to respond to appropriate medical therapy. Crucially, several red flags contraindicate balloon dilation, most notably symptoms suggestive of patulous ETD. Other contraindications include nasopharyngeal masses, active inflammatory diseases affecting the Eustachian tube, and craniofacial syndromes.

The risk of iatrogenic patulous ETD following balloon dilation, estimated at approximately 7%, underscores the critical need for thorough pre-operative screening. While most post-dilation patulous symptoms are mild and self-limiting, severe cases can occur, and factors like repeat dilation or significant pre-operative inflammation may increase this risk. Patients with TMJ dysfunction, hydrops, superior canal dehiscence, migraines, or pre-existing patulous physiology are considered poor candidates for balloon dilation.

Evidence supporting balloon dilation in adults with obstructive ETD is growing. Several trials have demonstrated significant improvements in quality of life, as measured by the Eustachian Tube Dysfunction Questionnaire (ETDQ-7), with one study reporting a 94% improvement and 83% patient satisfaction after 30 months of follow-up. Objective improvements in tympanometry and tympanic membrane appearance have also been documented. While systematic reviews generally support balloon dilation in appropriately selected patients, limitations such as small sample sizes and heterogeneous patient populations persist in much of the existing literature.

Complications from balloon dilation are generally rare and minor, with subcutaneous/cervicofacial emphysema and pneumomediastinum being the most frequently reported rare adverse events.

For otolaryngologists seeking to incorporate balloon dilation into their practice, meticulous documentation and accurate coding are essential for reimbursement. Payers often require detailed records of symptom duration, severity, objective findings, prior medical treatments, and a clear exclusion of differential diagnoses. The American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) provides coding guidance, with CPT codes 69705 for unilateral and 69706 for bilateral procedures.

Pediatric Balloon Dilation: A Landscape of Evolving Evidence

The application of balloon dilation in pediatric patients presents a more complex and less defined landscape. While the procedure received FDA clearance for children and adolescents aged 8 to 17 in 2023, the evidence base remains limited, and the etiologies of ETD in children often differ significantly from adults.

Dr. Lieu emphasized that the leading cause of ETD in young children is recurrent upper respiratory infections, in contrast to the chronic obstructive or patulous forms seen in adults. ETD in children is frequently multifactorial and tends to improve with age as their anatomy and immune systems mature. This variability complicates the notion of a single intervention like balloon dilation providing a definitive solution.

The practical challenges of pediatric balloon dilation include the need for anesthesia, increasing procedure time and cost compared to traditional tympanostomy tube insertion. The cost of the single-use balloon dilator itself can be substantial. Current research, which includes a limited number of studies with small pediatric cohorts, makes it difficult to definitively parse out the specific benefits of balloon dilation for children. Comparisons with ventilation tubes are often hampered by dissimilar patient populations, indications, and outcome measures.

Key unanswered questions remain regarding pediatric balloon dilation. These include whether children benefit more from balloon dilation alone or in conjunction with ventilation tubes, how it compares to longer-term tube placements, and whether the higher cost of dilation is justified by its effectiveness. To address these gaps, efforts are underway to validate pediatric-specific quality-of-life surveys for ETD.

Currently, many pediatric otolaryngologists consider balloon dilation only after exhausting more traditional treatments. Ventilation tubes remain the first-line approach for children with otitis media with effusion and associated hearing dysfunction. Balloon dilation may be considered for children who experience recurrent problems despite multiple tube insertions or after other evidence-based interventions have failed.

The expanded FDA availability of balloon dilation for pediatric patients, while a step forward, does not signify a universal solution. As with adults, careful patient selection, rigorous documentation, and a commitment to ongoing research are essential to optimize outcomes and ensure the appropriate application of this evolving therapeutic modality. The journey from a simple complaint of a “blocked ear” to a precise diagnosis and effective treatment remains a testament to the intricate science of otolaryngology.